Major Drivers Propelling the Growth oh theHepatitis C Market Forward: Rising Viral Infections Fueling Advancements In The Hepatitis C Market
Discover trends, market shifts, and competitive outlooks for the hepatitis c industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has The Hepatitis C Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size for hepatitis C has seen significant expansion in the past few years. The growth is projected to increase from $67.17 billion in 2024 to $76.32 billion in 2025 with a compound annual growth rate (CAGR) of 13.6%. The substantial growth during the previous period can be explained by factors such as blood transfusion procedures, use of injection drugs, scarcity of treatment alternatives, and the innovation of direct-acting antivirals (DaaS).
Forecasted robust expansion is expected for the hepatitis C market in the upcoming years, as it’s anticipated to skyrocket to a valuation of $134.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The substantial growth through the forecast period is a result of international eradication strategies, enhanced testing and screening procedures, escalating healthcare expenditure, the inclusion of telemedicine, and the advent of new therapeutic mixtures. Key trends within this forecast period encompass accessible and cost-effective treatments, an emphasis on groups at high risk, advanced drug formulations, collective initiatives and alliances, and the implementation of telehealth and digital solutions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Hepatitis C Market?
The growth of the hepatitis C market is projected to be driven by an upsurge in viral infections. These are infections impelled by a virus in the body. The therapy for hepatitis C diminishes viral infection by eradicating it and reinstating immune response in hepatitis C patients following viral clearance. To exemplify, the Centers for Disease Control and Prevention, a health agency based in the US, denoted in August 2024 that the incidence rate of individuals with Parvovirus B19, a seasonal viral infection of the respiratory system, inflated across all age brackets, escalating from 3% in the span of 2022–2024 to 10% in June 2024. Amongst these, the most substantial increment was marked in children within the age range of 5–9 years, where the prevalence amplified from 15% in the span of 2022–2024 to 40% by June 2024. Furthermore, the number of combined samples having parvovirus B19 DNA levels has significantly ascended from 1.5% in December 2023 to 19.9% in June 2024. Therefore, the escalation in viral infections is fueling the growth of the hepatitis C market.
Which Key Market Segments Comprise the Hepatitis C Market and Drive Its Revenue Growth?
The hepatitis C market covered in this report is segmented –
1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types
2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments
3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis
4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings
Subsegments:
1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6
2) By Acute Hepatitis C: Symptomatic, Asymptomatic
3) By Other Types: Mixed Infections, Superinfection
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp
Which Areas Are Leading Regions in the Hepatitis C Market Expansion Across the Globe?
North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Key Market Trends in theHepatitis C Market Over the Coming Years?
The growing prominence of innovative diagnostic technology for hepatitis C serves as a critical trend in the hepatitis C market. Maintaining a competitive edge within the sector, established firms are leveraging new advancements. A noteworthy example is the Switzerland-based F. Hoffmann-La Roche Ltd., which in July 2022 introduced its Elecsys HCV Duo immunoassay in regions recognizing the CE Mark. Employing this immunoassay, the hepatitis C virus (HCV) antigen and antibody levels can be simultaneously and independently assessed using one plasma or serum sample from a human. This test enables the detection of patients recovering from, or showing signs of, a chronic infection that may precipitate other health conditions, such as early-stage disorders and liver cancer.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report
How Is the Hepatitis C Market Conceptually Defined?
Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation, liver damage, and potentially cirrhosis or liver cancer if untreated. It spreads through contact with infected blood and is treated using antiviral medications aimed at eradicating the virus from the bloodstream.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
